Appalaches Capital
Our archive holds 8 letters from Appalaches Capital, behind 8 investment theses and positions in 4 companies. Every quote below is copied verbatim from the letter it came from.
Appalaches Capital’s own letters pageWhat they bought and sold · 4 moves
- June 2026
“We increased our stakes in AutoZone, CME Group, and Progressive.”
Read the letter - AddedCME Group Inc.June 2026
“We increased our stakes in AutoZone, CME Group, and Progressive.”
Read the letter - New positionMcKesson CorporationJune 2026
“We also made a new investment in McKesson Corporation and had other smaller purchases.”
Read the letter - AddedAutoZone, Inc.June 2026
“We increased our stakes in AutoZone, CME Group, and Progressive.”
Read the letter
Companies held · 4
Every company Appalaches Capital has disclosed a position in across our archive, with the letter that last mentioned it.
- AutoZone, Inc.Jun 2026
- CME Group Inc.Jun 2026
- McKesson CorporationJun 2026
- Progressive CorporationJun 2026
Theses · 8
- June 2026
McKesson benefits from its dominant drug distribution role, structural barriers to entry, improving generic and biosimilar economics, high ROIC, and an attractive valuation.
Read the full thesis - June 2026
AutoZone is investing in Mega Hubs and distribution capabilities to improve availability and commercial competitiveness, with earnings growth expected to rebound as the buildout peaks.
Read the full thesis - March 2026
Visa is a scaled, low-cost global payments network with durable moats and limited long-term risk from regulation or agentic AI, and stands to benefit from innovation and international growth.
Read the full thesis - March 2026
Mastercard is a scaled, low-cost global payments network with strong competitive advantages and minimal long-term risk from regulation or AI, and is positioned to benefit from innovation and international growth.
Read the full thesis - September 2025
Progressive is a leading auto insurer that leverages data and analytics to offer competitive rates and consistently profitable underwriting, positioning itself for continued growth in the market.
Read the full thesis - June 2025
Eagle Materials defies conventional valuation models by uniquely blending upstream resource ownership with high-return cement and wallboard operations, offering rare pricing power and capital discipline that are often misunderstood by the market.
Read the full thesis - March 2025
Arch Capital’s disciplined underwriting and long-term incentive model minimize agency costs—positioning it as a top-tier insurer trading cheaply despite structural tailwinds and standout profitability.
Read the full thesis - March 2025
ASML Holding N.V. is a leading provider of EUV lithography tools with significant pricing power and strong growth prospects, while Lam Research Corporation offers critical etch and deposition tools with potential for recovery in the semiconductor industry.
Read the full thesis
Letter archive · 8
2025
Funds · 2
- Appalaches Capital7
- Appalaches Core LO1
Get Appalaches Capital’s next letter the day it lands
We track Appalaches Capital alongside hundreds of other managers, read every letter, and pull out what they bought and sold. Warren AI reads the whole archive for you.
View plans→